Navigation Links
Coalition for Pulmonary Fibrosis Announces Awards and Activities at ATS International Conference
Date:5/18/2009

CPF Recognized for Advancing Research and Patient Advocacy Efforts

SAN DIEGO, May 18 /PRNewswire-USNewswire/ -- The Coalition for Pulmonary Fibrosis (CPF) today announced awards received at the American Thoracic Society's (ATS) International conference in San Diego, Calif. being held this week. The ATS meeting brings together the world's leading pulmonary, critical care and sleep physicians. The CPF received an award for a partner grant program with ATS that, to date, has funded $400,000 in new pulmonary fibrosis research funding. The organization also received a first-time award for its participation in the ATS Public Advisory Roundtable (PAR). The CPF is exhibiting in booth #2921 on "PAR Row" at the International meeting.

The CPF has partnered with the ATS since 2006 to provide peer-reviewed grants for innovative research in PF. To date, the CPF/ATS partner grant program has awarded grants to PF researchers at Johns Hopkins University (Baltimore, MD), Massachusetts General Hospital (Boston, Mass.), Ohio State University Medical Center (Columbus, Ohio) and Vanderbilt University Medical Center (Nashville, Tenn.).

"We are pleased to receive some very prestigious awards from ATS, and we're proud to continue this exciting partnership with ATS," said Mishka Michon, CEO of the CPF.

The CPF received the ATS Foundation's inaugural "Breathing for Life Award" for its participation in the ATS PAR, the patient voice of the ATS. The ATS PAR has created unparalleled synergy with ATS members by involving patients in providing support, shaping public policy and stimulating new research.

Due to the CPF's involvement with ATS and combined efforts to further educate doctors and researchers on PF, the disease is gaining more attention and PF is the subject of an increasing number of high profile sessions at the international conference. Sessions on PF at this year's meeting have included topics ranging from basic research areas in lung stem cells as well as clinical and translational research from bench to bedside.

The CPF also awarded an ATS travel grant, provided to fund a PF researcher's conference travel, to James P. Bridges, Ph.D. from Cincinnati Children's Hospital and Medical Center.

For a schedule of ATS events, please visit http://www.thoracic.org/sections/meetings-and-courses/international-conference/2009/index.html.

About Pulmonary Fibrosis (PF)

Pulmonary Fibrosis (PF) is a lung disorder characterized by a progressive scarring -- known as fibrosis -- and deterioration of the lungs, which slowly robs its victims of their ability to breathe. Approximately 128,000 Americans suffer from PF, and there is currently no known cause or cure. An estimated 48,000 new cases are diagnosed each year. PF is difficult to diagnose and an estimated two-thirds of patients die within five years of diagnosis. Sometimes PF can be linked to a particular cause, such as certain environmental exposures, chemotherapy or radiation therapy, residual infection, or autoimmune diseases such as scleroderma or rheumatoid arthritis. However, in many instances, no known cause can be established. When this is the case, it is called idiopathic pulmonary fibrosis (IPF).

About the CPF

The CPF is a 501(c)(3) nonprofit organization, founded in 2001 to accelerate research efforts leading to a cure for pulmonary fibrosis (PF), while educating, supporting, and advocating for the community of patients, families, and medical professionals fighting this disease. The CPF funds promising research into new approaches to treat and cure PF; provides patients and families with comprehensive education materials, resources, and hope; serves as a voice for national advocacy of PF issues; and works to improve awareness of PF in the medical community as well as the general public. The CPF's nonprofit partners include many of the most respected medical centers and healthcare organizations in the U.S. With more than 19,000 members nationwide, the CPF is the largest nonprofit organization in the U.S. dedicated to advocating for those with PF. For more information please visit www.coalitionforpf.org or call (888) 222-8541.


'/>"/>
SOURCE Coalition for Pulmonary Fibrosis
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. United Concordia and Texas Oral Health Coalition Partner to Offer Free Dental Services
2. Coalition for Quality & Patient Safety of Chicagoland PSO Taps ECRI Institute PSO for Patient Safety Support
3. Concord Coalition Says New Trustees Report Demonstrates the Importance of Health Care Cost Control
4. PhRMA Statement on Healthcare Reform Coalition
5. Bipartisan Coalition Forms to Call for Chronic Disease to be Key Focus of Health Reform in Indiana and Nationally
6. Latino Coalition Highlights Importance of Personal Health Records At Economic Summit
7. Industry Coalition Advises Against Use of Dietary Supplements as Swine Flu Remedy, Cure
8. Coalition Says On-Site Infectious Medical Waste Treatment Key To Disease Control and Hospital Sustainability During a Pandemic
9. Obama Judicial Nominee Opposed By Coalition of Disability Rights Organizations
10. Coalition of Leaders in Science and Research Commend Obama Administration for Commitment to Medical Innovation During First 100 Days
11. Coalition to Protect Senior Care Applauds Inclusion of Long Term Care in Senate Finance Committee Roundtable Discussion on Health Care Delivery System Reform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... Steven Tonkinson, ... he has completed every year since it started in 2003. This year, he ran ... attention of fellow runners and NBA team the Miami Heat. , This Sunday, while ...
(Date:2/5/2016)... ... February 05, 2016 , ... Today, the Whole-Food Warrior TV show, ... much-anticipated feature with author Jahnavi Foster, specialist in healthy vegetarian cuisine, will stream on ... week, on his weekly Whole-Food Warrior TV show, Frank Davis highlights Whole-Food Warriors - ...
(Date:2/5/2016)... ... 05, 2016 , ... The Muscular Dystrophy Association and Sailormen ... the 14th annual “Appetite for a Cure” campaign on Feb. 1 to raise ... related diseases that severely limit strength and mobility. , Now through March ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... George H. Van Allen have signed a joint enrollment and degree completion agreement. ... pathway toward associate and baccalaureate degrees at FHU|Dickson. , The agreement allows ...
(Date:2/5/2016)... ... 2016 , ... US Sports Camps , official operators of Nike Yoga ... kids yoga training. ChildLight Yoga Studio is centrally situated in the picturesque New England ... Yoga Studio founder Lisa Flynn expresses her excitement, “We are thrilled to be partnering ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... Wegener Polyangiitis - Pipeline Review, H2 ... Polyangiitis - Pipeline Review, H2 2015, provides an ... This report provides comprehensive information on the therapeutic ... at various stages, therapeutics assessment by drug target, ... and molecule type, along with latest updates, and ...
(Date:2/4/2016)... Frontier Pharma: Chronic Obstructive Pulmonary Disease ... Chronic Obstructive Pulmonary Disease (COPD) is ... the airways and lungs. Persistent breathing difficulties and ... one of the leading causes of morbidity and ... COPD is linked to cumulative exposure to risk ...
(Date:2/4/2016)... 2016 In response to the opioid abuse epidemic, ... for Medical Products and Tobacco, along with other FDA leaders, ... approach to opioid medications. The plan will focus on policies ... pain access to effective relief. --> ... Re-examine the risk-benefit paradigm for opioids and ensure that the ...
Breaking Medicine Technology: